AI Science Tracker
EN

Prognostic prediction of pulmonary neuroendocrine carcinoma using a transformer-based artificial intelligence model: a two-center retrospective cohort study.

Peking Union Medical College Hospital; Chinese Academy of Medical Sciences · 23 Oct 2026 · medicine

Discovery

Prognostic prediction of pulmonary neuroendocrine carcinoma using a transformer-based artificial intelligence model: a two-center retrospective cohort study.

Source check: Source checked. Not independent scientific confirmation.

Finding: A two-center retrospective cohort compared a transformer-based model with conventional approaches for overall and disease-free survival prediction. The best-performing model differed by endpoint, so performance should be described by task rather than as one universal winner.

Technology: Transformer-based survival prediction model

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Transformer-based survival prediction model
Test and result
Two-center retrospective cohort evaluation reported model-specific discrimination for overall and disease-free survival.
Limitation / still unknown
Retrospective cohorts do not establish prospective clinical benefit; the strongest model varied by endpoint.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fonc.2026.1948262

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.